Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1083821
Max Phase: Preclinical
Molecular Formula: C15H12O4
Molecular Weight: 256.26
Molecule Type: Small molecule
Associated Items:
ID: ALA1083821
Max Phase: Preclinical
Molecular Formula: C15H12O4
Molecular Weight: 256.26
Molecule Type: Small molecule
Associated Items:
Synonyms (1): (E)-3,2',4'-Trihydroxychalcone
Synonyms from Alternative Forms(1):
Canonical SMILES: O=C(/C=C/c1cccc(O)c1)c1ccc(O)cc1O
Standard InChI: InChI=1S/C15H12O4/c16-11-3-1-2-10(8-11)4-7-14(18)13-6-5-12(17)9-15(13)19/h1-9,16-17,19H/b7-4+
Standard InChI Key: WKMQGQZPDSFACZ-QPJJXVBHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 256.26 | Molecular Weight (Monoisotopic): 256.0736 | AlogP: 2.70 | #Rotatable Bonds: 3 |
Polar Surface Area: 77.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.11 | CX Basic pKa: | CX LogP: 3.63 | CX LogD: 3.15 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.58 | Np Likeness Score: 0.67 |
1. Mativandlela SP, Muthivhi T, Kikuchi H, Oshima Y, Hamilton C, Hussein AA, van der Walt ML, Houghton PJ, Lall N.. (2009) Antimycobacterial flavonoids from the leaf extract of Galenia africana., 72 (12): [PMID:20035557] [10.1021/np800778b] |
2. Hofmann E, Webster J, Do T, Kline R, Snider L, Hauser Q, Higginbottom G, Campbell A, Ma L, Paula S.. (2016) Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers., 24 (4): [PMID:26762836] [10.1016/j.bmc.2015.12.024] |
3. Xie Z, Luo X, Zou Z, Zhang X, Huang F, Li R, Liao S, Liu Y.. (2017) Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia., 27 (15): [PMID:28655421] [10.1016/j.bmcl.2017.01.053] |
4. Cai CY, Rao L, Rao Y, Guo JX, Xiao ZZ, Cao JY, Huang ZS, Wang B.. (2017) Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates., 130 [PMID:28242551] [10.1016/j.ejmech.2017.02.007] |
5. Selvaraj B, Kim DW, Huh G, Lee H, Kang K, Lee JW.. (2020) Synthesis and biological evaluation of isoliquiritigenin derivatives as a neuroprotective agent against glutamate mediated neurotoxicity in HT22 cells., 30 (8): [PMID:32122738] [10.1016/j.bmcl.2020.127058] |
Source(1):